Fig. 3.
Unweighted mean romiplostim dose over the 24-week follow-up period. *<3 months from diagnosis; †3–12 months from diagnosis; ‡>12 months from diagnosis. ITP, immune thrombocytopenia.
Unweighted mean romiplostim dose over the 24-week follow-up period. *<3 months from diagnosis; †3–12 months from diagnosis; ‡>12 months from diagnosis. ITP, immune thrombocytopenia.
